These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29860566)

  • 1. Systemic lupus erythematosus, gender differences in Colombian patients.
    Santamaría-Alza Y; Motta JZN; Fajardo-Rivero JE; Pineda CLF
    Clin Rheumatol; 2018 Sep; 37(9):2423-2428. PubMed ID: 29860566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute respiratory involvement in Colombian patients with systemic lupus erythematosus undergoing chest computed tomography.
    Santamaria-Alza Y; Sanchez-Bautista J; Fajardo-Rivero JE; Figueroa Pineda CL
    Int J Rheum Dis; 2019 Oct; 22(10):1825-1831. PubMed ID: 31496073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort.
    Riveros Frutos A; Casas I; Rúa-Figueroa I; López-Longo FJ; Calvo-Alén J; Galindo M; Fernández-Nebro A; Pego-Reigosa JM; Olivé Marqués A;
    Lupus; 2017 Jun; 26(7):698-706. PubMed ID: 27799439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive fungal infections in Colombian patients with systemic lupus erythematosus.
    Santamaría-Alza Y; Sánchez-Bautista J; Fajardo-Rivero JF; Figueroa CL
    Lupus; 2018 Jun; 27(7):1116-1122. PubMed ID: 29536803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
    Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA;
    Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and epidemiologic characterization of patients with systemic lupus erythematosus admitted to an intensive care unit in Colombia.
    Alvarez Barreneche MF; Mcewen Tamayo WD; Montoya Roldan D; Rodriguez Padilla LM; Velasquez Franco CJ; Mesa Navas MA
    Adv Rheumatol; 2019 Jul; 59(1):29. PubMed ID: 31292001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, serologic, and immunogenetic characterization (HLA-DRB1) of late-onset lupus erythematosus in a Colombian population.
    Peñaranda-Parada E; Quintana G; Yunis JJ; Mantilla R; Rojas W; Panqueva U; Caminos JE; Garces MF; Sanchez E; Rondón-Herrera F; de Jesús Iglesias-Gamarra A
    Lupus; 2015 Oct; 24(12):1293-9. PubMed ID: 26022697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome.
    Edwards CJ; Lian TY; Badsha H; Teh CL; Arden N; Chng HH
    Lupus; 2003; 12(9):672-6. PubMed ID: 14514129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence and prevalence of systemic lupus erythematosus in Thrace, 2003-2014: A 12-year epidemiological study.
    Pamuk ON; Balci MA; Donmez S; Tsokos GC
    Lupus; 2016 Jan; 25(1):102-9. PubMed ID: 26345673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome.
    Jung SM; Moon SJ; Kwok SK; Ju JH; Park KS; Park SH; Kim HY
    Lupus; 2013 Aug; 22(9):885-91. PubMed ID: 23846231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive fungal infections in Argentine patients with systemic lupus erythematosus.
    Vinicki JP; Catalan Pellet S; Pappalardo C; Cruzat VC; Spinetto MA; Dubinsky D; Tiraboschi IN; Laborde HA; Nasswetter G
    Lupus; 2013 Aug; 22(9):892-8. PubMed ID: 23861029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes and factors related to hospitalizations in patients with systemic lupus erythematosus: analysis of a 20-year period (1995-2015) from a single referral centre in Catalonia.
    Rosa GPD; Ortega MF; Teixeira A; Espinosa G; Cervera R
    Lupus; 2019 Aug; 28(9):1158-1166. PubMed ID: 31299879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: association with disease activity, nephritis, smoking, and age.
    Medeiros MM; Xavier de Oliveira ÍM; Ribeiro ÁT
    Rheumatol Int; 2016 Jan; 36(1):117-24. PubMed ID: 26149124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian Insufficiency is Major Short-term Toxicity in Systemic Lupus Erythematosus Patients Treated with Cyclophosphamide.
    Singh G; Misra R; Aggarwal A
    J Assoc Physicians India; 2016 Feb; 64(2):28-31. PubMed ID: 27730777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus.
    Feng X; Zou Y; Pan W; Wang X; Wu M; Zhang M; Tao J; Zhang Y; Tan K; Li J; Chen Z; Ding X; Qian X; Da Z; Wang M; Sun L
    Lupus; 2014 Mar; 23(3):327-34. PubMed ID: 24297642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
    Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
    J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register.
    Sousa S; Gonçalves MJ; Inês LS; Eugénio G; Jesus D; Fernandes S; Terroso G; Romão VC; Cerqueira M; Raposo A; Couto M; Nero P; Sequeira G; Nóvoa T; Melo Gomes JA; da Silva JC; Costa L; Macieira C; Silva C; Silva JA; Canhão H; Santos MJ
    Rheumatol Int; 2016 Jul; 36(7):955-60. PubMed ID: 26979603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus.
    Pego-Reigosa JM; Rúa-Figueroa Í; López-Longo FJ; Galindo-Izquierdo M; Calvo-Alén J; Olivé-Marqués A; del Campo V; García-Yébenes MJ; Loza-Santamaría E; Blanco R; Melero-González R; Vela-Casasempere P; Otón-Sánchez T; Tomero-Muriel E; Uriarte-Isacelaya E; Fito-Manteca MC; Freire-González M; Narváez J; Fernández-Nebro A; Zea-Mendoza A; Rosas J;
    Lupus; 2015 Jun; 24(7):720-9. PubMed ID: 25516473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of systemic lupus erythematosus on oral health-related quality of life.
    Corrêa JD; Branco LGA; Calderaro DC; Mendonça SMS; Travassos DV; Ferreira GA; Teixeira AL; Abreu LG; Silva TA
    Lupus; 2018 Feb; 27(2):283-289. PubMed ID: 28679308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse alveolar hemorrhage in Colombian patients with systemic lupus erythematosus.
    Cañas C; Tobón GJ; Granados M; Fernández L
    Clin Rheumatol; 2007 Nov; 26(11):1947-9. PubMed ID: 17377738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.